Montara Therapeutics
SAN FRANCISCO, CA · Biotechnology · 21 employees
Montara Therapeutics is a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and do
Funding history
- Funding Round — $20.0M — Mar 2025
- Funding Round — $8.0M — Jan 2024
Recent signals
- Jun 04, 2026: Raised funding
- Dec 08, 2025: Montara Appoints Jeremy Grunstein as Chief Business Officer
- Mar 13, 2025: Raised $20.0M
- Jul 30, 2024: Montara Therapeutics Partners with SV Health Investors’ Dementia Discovery Fund and Two Bear Capital to Develop Safer, More Effective Neuroscience Drugs
- Jan 19, 2024: Raised $8.0M
See plans & pricing → Track Montara Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.